Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Abstract

Background Supplementation of citicoline (CDP-choline), a naturally occurring mononucleotide, has shown beneficial effects on memory function and behavior in populations with a wide range of impairments. However, few studies have investigated its effect in healthy older populations. Objective The objective of this study was to investigate the effects of citicoline (Cognizin®), on memory in healthy elderly populations with age-associated memory impairment (AAMI). Methods A total of 100 healthy men and women aged between 50 and 85 y with AAMI participated in this randomized, double-blind, placebo-controlled trial. Participants were randomized to receive placebo (n = 51) or citicoline (n = 49; 500 mg/d) for 12 wk. Memory function was assessed at baseline and end of the intervention (12 wk) using computerized tests (Cambridge Brain Sciences, Ontario, Canada). Safety measurements included adverse events query, body weight, blood pressure, and hematology and metabolic panel. Intent-to-treat analysis was conducted using ANCOVA for the primary and secondary outcome variables with Bonferroni correction for multiple comparisons. Results A total of 99 out of 100 participants completed the study in its entirety. After the 12-wk intervention, participants supplemented with citicoline showed significantly greater improvements in secondary outcomes of episodic memory (assessed by the Paired Associate test), compared with those on placebo (mean: 0.15 vs. 0.06, respectively, P = 0.0025). Composite memory (secondary outcome), calculated using the scores of 4 memory tests, also significantly improved to a greater extent following citicoline supplementation (mean: 3.78) compared with placebo (mean: 0.72, P = 0.0052). Conclusions Dietary supplementation of citicoline for 12 wk improved overall memory performance, especially episodic memory, in healthy older males and females with AAMI. The findings suggest that regular consumption of citicoline may be safe and potentially beneficial against memory loss due to aging. This trial was registered at clinicaltrials.gov as NCT03369925.

Neurobehavioral and biochemical effects of choline chloride administration in rats

“…Previous studies showed that choline in the form of neurotransmitter (acetylcholine) plays an important role in the learning and memory. 16 It has been also reported earlier that choline supplementation increase learning and memory function in the fetal that exposes with alcohol. 17 In the present study we used water maze to assess memory function.…”

The Impact of Supplements on Recovery After Peripheral Nerve Injury: A Review of the Literature

“…Cytidine 5’-diphosphocholine, also known as Citicoline or CDP-choline, is a naturally occurring nucleotide that plays an essential role in phospholipid synthesis [ 36 ]. When provided exogenously, CDP-choline divides into choline and cytidine and serve as substrates for phospholipid synthesis [ 37 ].…”

Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo‐controlled study

“…Studies have also reported benefits to IR and working memory form taking B. monnieri (Calabrese et al., 2008; Pase et al., 2011; Sadhu et al., 2014; Stough et al., 2008). Mind Lab Pro also contains 250 mg of Citicoline, a substance which has been found to improve memory by increasing specific hormonal levels and activate biosynthesis in the central nervous system to protect cell membranes in healthy and unhealthy populations (Gareri et al., 2015; McGlade et al., 2012; Nakazaki et al., 2021). Nootropics such as Alpha Brain and Noocube also contain B. monnieri and also report benefits to memory.…”